Clinical Trial Update: NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy [NA]

View source ↗

Summary

A completed clinical trial evaluating the NaviFUS neuromodulation system for patients with drug-resistant epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• NaviFUS System

Snippet

Sponsor: NaviFUS Corporation | Conditions: Drug Resistant Epilepsy, Seizure | NA | Status: COMPLETED